Skip to main content
Signal8
Wolfe Josh profile photo

Josh Wolfe

CIK: 0001830001

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Eikon Therapeutics, Inc. logo
EIKN

Eikon Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Feb 6, 2026
    Conversion(C)
    Indirect
    2.4M shares-
  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Feb 6, 2026
    Conversion(C)
    Indirect
    1.2M shares-
  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Feb 6, 2026
    Conversion(C)
    Indirect
    2.2M shares-
  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Feb 4, 2026
    Purchase(P)
    Indirect
    138.9K shares at avg. $18.00$2.5M
  • Eikon Therapeutics, Inc. logo
    EIKN

    Eikon Therapeutics, Inc.

    Feb 4, 2026
    Purchase(P)
    Indirect
    138.9K shares at avg. $18.00$2.5M

1-5 of 5

About Wolfe Josh

Wolfe Josh (SEC CIK 0001830001) files insider reports with the SEC as Director of Eikon Therapeutics, Inc. (EIKN).

Signal8 holds 2 ownership filings by Wolfe Josh (1 Form 3, 1 Form 4), filed between Feb 4, 2026 and Feb 6, 2026. Those filings report 5 transactions, from Feb 4, 2026 to Feb 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wolfe Josh's filings is in MILLBRAE, CA.

Recent filings by Wolfe Josh

  • Feb 6, 2026: Conversions of EIKN shares (3 lines, Form 4, code C).
  • Feb 4, 2026: Open-market purchases of EIKN shares (2 lines, Form 4, code P).

Other insiders filing for Eikon Therapeutics, Inc. (EIKN)

How to read Form 4 transaction codes